What is the preferred treatment between Platelet-Rich Plasma (PRP) injections and steroid injections, such as methylprednisolone (methylprednisolone) or triamcinolone (triamcinolone), for Osteochondritis Dissecans (OCD) lesions in the knee?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of OCD Lesions in the Knee: PRP vs Steroids

Neither PRP nor corticosteroid injections are recommended or supported by evidence for the treatment of osteochondritis dissecans (OCD) lesions of the knee. The American Academy of Orthopaedic Surgeons (AAOS) guidelines do not address either injection therapy as a treatment option for OCD, and the standard of care remains activity modification, protected weight-bearing for stable lesions, or surgical intervention for unstable/failed conservative management 1.

Why These Injections Are Not Appropriate for OCD

Fundamental Difference from Osteoarthritis

  • OCD is a structural osteochondral lesion, not a degenerative joint disease 2, 3
  • The pathology involves disruption of subchondral bone blood supply with potential fragment separation, requiring mechanical healing or surgical fixation 2, 3
  • Both PRP and corticosteroids target inflammatory conditions like osteoarthritis, which is mechanistically different from OCD 4, 5

Lack of Evidence for Either Treatment

  • The AAOS systematic review found no studies evaluating injection therapies (PRP or corticosteroids) for OCD lesions 1
  • One small case series (6 patients) suggested PRP might help healing after surgical fixation of ICRS type III lesions, but this was used as an adjunct to surgery, not as primary treatment 6
  • Major orthopedic guidelines (ACR/AF, AAOS) recommend against PRP even for knee osteoarthritis due to lack of standardization and inconsistent evidence 5

Evidence-Based Treatment Algorithm for OCD

For Skeletally Immature Patients with Stable Lesions

  • Activity modification with protected weight-bearing for 3-6 months 2, 3
  • Serial imaging (radiographs and/or MRI) to monitor healing 1
  • If failed conservative treatment after ≥3 months: consider arthroscopic drilling 1, 2, 3

For Unstable or Displaced Lesions (Any Age)

  • Surgical intervention is recommended 1, 2, 3
  • Salvageable fragments: fixation with screws or bioabsorbable pins 2, 3
  • Unsalvageable fragments: cartilage repair techniques including bone marrow stimulation, osteochondral autograft transfer (OATS), or autologous chondrocyte implantation (ACI) 1, 2, 3

For Skeletally Mature Patients

  • Lower healing potential compared to immature patients 2, 3
  • Symptomatic patients with salvageable unstable lesions should be offered surgery 1
  • Treatment choice depends on fragment viability and size 3

Critical Pitfalls to Avoid

Do not treat OCD like osteoarthritis. The use of injections appropriate for degenerative joint disease (whether PRP or corticosteroids) is not supported for this structural osteochondral pathology 1, 2, 3.

Do not delay appropriate surgical referral. Patients with mechanical symptoms (locking, catching), unstable lesions on MRI, or failed conservative management require orthopedic surgical evaluation 2, 3.

Recognize the risk of progression to early osteoarthritis. OCD patients who remain symptomatic despite treatment have significant risk of developing severe osteoarthritis at a young age, making preservation of native cartilage the priority 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Osteochondritis Dissecans Lesions of the Knee: Evidence-Based Treatment.

The Journal of the American Academy of Orthopaedic Surgeons, 2024

Guideline

Platelet-Rich Plasma Therapy for Hip Osteoarthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Platelet-Rich Plasma Therapy for Knee Pain: Guideline Recommendations and Medicare Coverage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Osteochondritis dissecans-Does platelet rich plasma really help.

Journal of clinical orthopaedics and trauma, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.